Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.

Pathological cardiomyocyte hypertrophy is associated with significantly increased risk of heart failure, one of the leading medical causes of mortality worldwide. MicroRNAs are known to be involved in pathological cardiac remodeling. However, whether miR-99a participates in the signaling cascade lea...

Full description

Bibliographic Details
Main Authors: Qiaoling Li, Jun Xie, Bingjian Wang, Ran Li, Jian Bai, Liang Ding, Rong Gu, Lian Wang, Biao Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4767297?pdf=render
_version_ 1818308911804973056
author Qiaoling Li
Jun Xie
Bingjian Wang
Ran Li
Jian Bai
Liang Ding
Rong Gu
Lian Wang
Biao Xu
author_facet Qiaoling Li
Jun Xie
Bingjian Wang
Ran Li
Jian Bai
Liang Ding
Rong Gu
Lian Wang
Biao Xu
author_sort Qiaoling Li
collection DOAJ
description Pathological cardiomyocyte hypertrophy is associated with significantly increased risk of heart failure, one of the leading medical causes of mortality worldwide. MicroRNAs are known to be involved in pathological cardiac remodeling. However, whether miR-99a participates in the signaling cascade leading to cardiac hypertrophy is unknown. To evaluate the role of miR-99a in cardiac hypertrophy, we assessed the expression of miR-99a in hypertrophic cardiomyocytes induced by isoprenaline (ISO)/angiotensin-II (Ang II) and in mice model of cardiac hypertrophy induced by transverse aortic constriction (TAC). Expression of miR-99a was evaluated in these hypertrophic cells and hearts. We also found that miR-99a expression was highly correlated with cardiac function of mice with heart failure (8 weeks after TAC surgery). Overexpression of miR-99a attenuated cardiac hypertrophy in TAC mice and cellular hypertrophy in stimuli treated cardiomyocytes through down-regulation of expression of mammalian target of rapamycin (mTOR). These results indicate that miR-99a negatively regulates physiological hypertrophy through mTOR signaling pathway, which may provide a new therapeutic approach for pressure-overload heart failure.
first_indexed 2024-12-13T07:21:48Z
format Article
id doaj.art-e8b496ea62ee4e79b689c87871680a2b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T07:21:48Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e8b496ea62ee4e79b689c87871680a2b2022-12-21T23:55:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014848010.1371/journal.pone.0148480Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.Qiaoling LiJun XieBingjian WangRan LiJian BaiLiang DingRong GuLian WangBiao XuPathological cardiomyocyte hypertrophy is associated with significantly increased risk of heart failure, one of the leading medical causes of mortality worldwide. MicroRNAs are known to be involved in pathological cardiac remodeling. However, whether miR-99a participates in the signaling cascade leading to cardiac hypertrophy is unknown. To evaluate the role of miR-99a in cardiac hypertrophy, we assessed the expression of miR-99a in hypertrophic cardiomyocytes induced by isoprenaline (ISO)/angiotensin-II (Ang II) and in mice model of cardiac hypertrophy induced by transverse aortic constriction (TAC). Expression of miR-99a was evaluated in these hypertrophic cells and hearts. We also found that miR-99a expression was highly correlated with cardiac function of mice with heart failure (8 weeks after TAC surgery). Overexpression of miR-99a attenuated cardiac hypertrophy in TAC mice and cellular hypertrophy in stimuli treated cardiomyocytes through down-regulation of expression of mammalian target of rapamycin (mTOR). These results indicate that miR-99a negatively regulates physiological hypertrophy through mTOR signaling pathway, which may provide a new therapeutic approach for pressure-overload heart failure.http://europepmc.org/articles/PMC4767297?pdf=render
spellingShingle Qiaoling Li
Jun Xie
Bingjian Wang
Ran Li
Jian Bai
Liang Ding
Rong Gu
Lian Wang
Biao Xu
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
PLoS ONE
title Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
title_full Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
title_fullStr Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
title_full_unstemmed Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
title_short Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
title_sort overexpression of microrna 99a attenuates cardiac hypertrophy
url http://europepmc.org/articles/PMC4767297?pdf=render
work_keys_str_mv AT qiaolingli overexpressionofmicrorna99aattenuatescardiachypertrophy
AT junxie overexpressionofmicrorna99aattenuatescardiachypertrophy
AT bingjianwang overexpressionofmicrorna99aattenuatescardiachypertrophy
AT ranli overexpressionofmicrorna99aattenuatescardiachypertrophy
AT jianbai overexpressionofmicrorna99aattenuatescardiachypertrophy
AT liangding overexpressionofmicrorna99aattenuatescardiachypertrophy
AT ronggu overexpressionofmicrorna99aattenuatescardiachypertrophy
AT lianwang overexpressionofmicrorna99aattenuatescardiachypertrophy
AT biaoxu overexpressionofmicrorna99aattenuatescardiachypertrophy